Sophia Genetics (FRA:90B) Institutional Ownership: 12.13% (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:90B Sophia Genetics SA FRA:90B
68 GF Score
Price €4.84
GF Value €4.42
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Institutional Ownership?

Sophia Genetics FRA:90B -2.81% 68 Institutional Ownership is 12.13% as of Jul. 29, 2026. GuruFocus rates FRA:90B with a GF Score™ of 68/100 and a GF Value™ of €4.42 (Fairly Valued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sophia Genetics's institutional ownership is 12.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sophia Genetics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sophia Genetics's Float Percentage Of Total Shares Outstanding is 94.18%.


Sophia Genetics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sophia Genetics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Institutional Ownership Chart

Sophia Genetics Historical Data

The historical data trend for Sophia Genetics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 3.39 3.41 3.41 4.84 4.98 4.72 7.62 7.64 8.00 12.13
FRA:90B
68GF Score
Sophia Genetics SA FRA:90B
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sophia Genetics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 12.13% mean?
Sophia Genetics (FRA:90B) has a Institutional Ownership of 12.13% as of Jul. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sophia Genetics and its competitors.
Is Sophia Genetics' Institutional Ownership too high?
Sophia Genetics' current Institutional Ownership is 12.13%. Overall, Sophia Genetics has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Institutional Ownership compare to EVH and NRC?
Sophia Genetics' Institutional Ownership of 12.13% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Healthcare Providers & Services company?
A good Institutional Ownership depends on the Healthcare Providers & Services industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sophia Genetics and its competitors. Sophia Genetics's current Institutional Ownership is 12.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (FRA:90B) is currently considered Fairly Valued. The stock's GF Value™ is €4.42, compared to a current price of €4.84 — trading 9.5% above its estimated fair value. The current Institutional Ownership is 12.13%. Sophia Genetics' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sophia Genetics (FRA:90B), the current Institutional Ownership is 12.13% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (FRA:90B) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of €4.84 is trading 9.5% above its estimated GF Value™ of €4.42. GuruFocus considers Sophia Genetics to be Fairly Valued.

Key valuation signals for FRA:90B:

  • Institutional Ownership: 12.13%
  • GF Value™: €4.42 vs. price of €4.84 (9.5% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the FRA:90B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sophia Genetics Business Description

Other Exchanges SOPH:USA90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
68GF Score

Get the complete analysis for FRA:90B

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.84
Price
€4.42
GF Value